REEP5 and neoplasm: The lack of REEP5 mutations in the 23 validation cases that were screened suggests that germline REEP5 mutations are not common in sporadic AMTs/PMPs, however this is a small dataset of a very rare tumour type, and more cases are required to determine if REEP5 is implicated in the development of AMTs.